0

Likes

0

Recommended

0

Followers

Science Valley Research Institute

Sorry, but we don't have an email address for this listing

Sorry, but we don't have a location for this listing

Sorry, but we don't have a phone number for this listing

Sorry, but this listing is on a subscription plan which does not allow users to schedule meetings with them

Sorry, but this listing is on a subscription plan which does not allow users to view their website URL

Leading the Frontier in Clinical Research and Biotechnological Innovation.

This pioneering enterprise operates in the field of drug information, providing comprehensive technical and scientific services aimed at enhancing clinical research intelligence. Specializing in clinical trial operations and research and development, the organization contributes to the development of essential pharmaceuticals, raw materials, medications, surgical procedures, vaccines, cost-effectiveness studies, and health devices. With a focus on advancing human health and saving lives of patients with severe illnesses, it leverages cutting-edge technology and innovation to conduct both pre-clinical and clinical research, paving the way for the creation of new drugs, molecules, treatments, and medical devices. Its services extend to regulatory technical support, facilitating the approval process for clinical trial protocols, registration, manufacturing, patents, and commercialization of treatments and medical equipment.

With an extensive network of twenty-nine qualified research centers across eleven states, the organization is equipped to manage all phases of clinical trials, from Phase 1 through Phase 4, and even pre-clinical studies on occasion. Maintaining high standards in study design, data management, and academic publishing, it delivers robust R&D support essential for the development and registration of new, innovative pharmaceutical treatments. Adhering to good clinical research practices and regulatory guidelines by leading authorities like FDA and ANVISA, the entity ensures excellence in patient recruitment and monitoring. By 2026, it aspires to be the foremost Multicenter International Research Institute in strategic biotechnology areas such as RNA, mAbs, and recombinant proteins, focusing on significant pathologies including oncology, cardiology, endocrinology, neurology, and COVID-19.

Leading the Frontier in Clinical Research and Biotechnological Innovation.

This pioneering enterprise operates in the field of drug information, providing comprehensive technical and scientific services aimed at enhancing clinical research intelligence. Specializing in clinical trial operations and research and development, the organization contributes to the development of essential pharmaceuticals, raw materials, medications, surgical procedures, vaccines, cost-effectiveness studies, and health devices. With a focus on advancing human health and saving lives of patients with severe illnesses, it leverages cutting-edge technology and innovation to conduct both pre-clinical and clinical research, paving the way for the creation of new drugs, molecules, treatments, and medical devices. Its services extend to regulatory technical support, facilitating the approval process for clinical trial protocols, registration, manufacturing, patents, and commercialization of treatments and medical equipment.

With an extensive network of twenty-nine qualified research centers across eleven states, the organization is equipped to manage all phases of clinical trials, from Phase 1 through Phase 4, and even pre-clinical studies on occasion. Maintaining high standards in study design, data management, and academic publishing, it delivers robust R&D support essential for the development and registration of new, innovative pharmaceutical treatments. Adhering to good clinical research practices and regulatory guidelines by leading authorities like FDA and ANVISA, the entity ensures excellence in patient recruitment and monitoring. By 2026, it aspires to be the foremost Multicenter International Research Institute in strategic biotechnology areas such as RNA, mAbs, and recombinant proteins, focusing on significant pathologies including oncology, cardiology, endocrinology, neurology, and COVID-19.

Show More

Recommendations (1)

All (1)
Recommendations (1)
Reviews (0)
Videos (0)
avtar-image
G D
12 hours ago
left a recommendation for